EGFR and glioblastoma: They also displayed, in pairwise comparisons, the accumulation of new SVs/CNVs in known GBM and general oncogenic drivers (e.g., EGFR or CDK6 amplifications in G402R and G275R, respectively; Fig. 5a and Supplementary Fig. 9a, b).